• Subscribe for Free (RSS + E-mail)
    RSS + E-mail

    Napa Summit 2013 →

    Featured▾

    • Napa Summit 2013 →

  • Xconomy Boston

  • Xperience
    Tech + Life▾
      • Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
        Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
      • Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
        Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
      • Online Galleries Help Shoppers Get Smart About Art
        Online Galleries Help Shoppers Get Smart About Art
      • Do You Need an Extended Warranty? Do the Math, Says SquareTrade
        Do You Need an Extended Warranty? Do the Math, Says SquareTrade
      • LG Parties with Optimus G Pro, Pulls a Note or II from Samsung
        LG Parties with Optimus G Pro, Pulls a Note or II from Samsung
      View More in Xperience ›
  • Our
    Cities▾
    • Boston›
      • CommonAngels Pledges 20 Startup Tix for XSITE June 19: Get Yours Here
        CommonAngels Pledges 20 Startup Tix for XSITE June 19: Get Yours Here
      View More in Boston ›
    • Boulder/Denver›
      • Dream Chaser Reaches Edwards AFB to Prove It Has “The Right Stuff”
        Dream Chaser Reaches Edwards AFB to Prove It Has “The Right Stuff”
      View More in Boulder/Denver ›
    • Detroit›
      • Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview
        Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview
      View More in Detroit ›
    • New York›
      • Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs
        Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs
      View More in New York ›
    • San Diego›
      • Effector Therapeutics Raises $45M to Prove New Concept in Cancer
        Effector Therapeutics Raises $45M to Prove New Concept in Cancer
      View More in San Diego ›
    • San Francisco›
      • Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview
        Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview
      View More in San Francisco ›
    • Seattle›
      • Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections
        Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections
      View More in Seattle ›
    • Texas›
      • Texas Venture Capital Market ‘Weak,’ But Still Shows Promise
        Texas Venture Capital Market ‘Weak,’ But Still Shows Promise
      View More in Texas ›
  • Tech
    Channels ▾
    • Cleantech›
      • EcoMotors CEO Talks $200M Deal With Chinese Manufacturer
        EcoMotors CEO Talks $200M Deal With Chinese Manufacturer
      View More in Cleantech ›
    • Health IT›
      • Tigerlabs Health Accelerator to Pair Corporate Needs with Startups
        Tigerlabs Health Accelerator to Pair Corporate Needs with Startups
      View More in Health IT ›
    • Life Sciences›
      • San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More
        San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More
      View More in Life Sciences ›
    • Mobile›
      • Coolhouse Labs: The Accelerator With a View of Lake Michigan
        Coolhouse Labs: The Accelerator With a View of Lake Michigan
      View More in Mobile ›
    • Startups›
      • Pivotal Seeks Better Enterprise Cloud, with EMC Roots and GE Cash
        Pivotal Seeks Better Enterprise Cloud, with EMC Roots and GE Cash
      View More in Startups ›
  • Meet the
    Xconomists ▾
    • cdevore

      Chris DeVore

      General Partner at Founder's Co-op

    • bfeld

      Brad Feld

      Managing director, the Foundry Group

    • bdalton

      Barbara Dalton

      VP of Venture Capital, Pfizer Inc.

    • bratner

      Buddy Ratner

      Professor of Bioengineering, University of Washington

    • Meet All the Xconomists ›
    • hrheingold

      Howard Rheingold

      Founder, Social Media Classroom

    • pthompson

      Peter Thompson

      Venture Partner, OrbiMed Advisors

    • sparker

      H. Stewart Parker

      CEO, Infectious Disease Research Institute

    • dwilliams

      Doug Williams

      Executive VP of R&D, Biogen Idec

  • Our
    Events ▾
    • The Napa Summit 2013: New Rules for Growth

      6/3/13 · San Francisco

      The Napa Summit 2013: New Rules for Growth
    • XSITE 2013: Boston’s Tech Revival

      6/19/13 · Boston

      XSITE 2013: Boston’s Tech Revival
    • View All Xconomy Events › Boston Events ›
    • Boulder/Denver Events › Detroit Events ›
    • New York Events › San Diego Events ›
    • San Francisco Events › Seattle Events ›
    • Texas Events ›
  • Boston Home
  • Boston Events
  • Local Jobs
  • Archives
  • Xconomists
  • X Lists
  • VC / M&A Deals

From Biogen Idec’s ALS Drug Fails Phase III Trial:

biogen idec logo
biogen idec logo—

Underwriters and Partners

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Connect with Xconomy

  • Xconomy on Facebook
  • Xconomy on Twitter
  • Xconomy on Linkedin
  • Xconomy on Google PLus
  • Xconomy Feeds

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy
  • Home
  • Privacy/DMCA
  • About
  • Contact Us
  • Archives
  • Advertise
  • Subscribe for Free

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.